PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
12-Jul-2022 Connect in Pharma launches art exhibition and charity partnership to raise funds for rare disease research Sciad Newswire
12-Jul-2022 Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 2022 Heidelberg Pharma AG
12-Jul-2022 PolyPeptide Group provides market update PolyPeptide Group
11-Jul-2022 Accelerate Diagnostics Announces Commercialization in Europe of its Accelerate Arc™ System Having Completed IVDR Registration B3C newswire
08-Jul-2022 Weekly Pharma & Life Science News Round Up: 4th – 8th July PharmiWeb.Jobs
08-Jul-2022 Acer Therapeutics and Relief Therapeutics Announce That the China National Intellectual Property Administration (CNIPA) Issued Utility Model Patent 11,202,767 Covering ACER-001 Dosage Form Relief Therapeutics Holding SA
07-Jul-2022 Takeda places focus on personalized care and innovation for bleeding disorders at ISTH 2022 Takeda
07-Jul-2022 Grünenthal, Uniklinik RWTH Aachen and RTWH Aachen University collaborate to advance pain research Grünenthal
07-Jul-2022 ACTO Secures $18M Financing to Accelerate Growth and Strengthen Position as #1 Learning Platform in Life Sciences ACTO
07-Jul-2022 Merger of Rephine with Forum Auditorias & TDV creates clear market leader in global GMP audit services Rephine
07-Jul-2022 Destiny Pharma announces publication of XF-73 drug synergy data Destiny Pharma
07-Jul-2022 Spexis' CXCR4 inhibitor balixafortide demonstrates synergistic efficacy in combination with docetaxel in a metastatic prostate cancer preclinical model Spexis AG
06-Jul-2022 Foundation for the Industry's Next-stage Innovation and Growth ProtaGene
06-Jul-2022 Immutep granted Japanese patent for IMP761, a first-in-class immunosuppressive antibody targeting LAG-3 Immutep
06-Jul-2022 Nordic Nanovector to Discontinue PARADIGME, its Phase 2b Trial with Betalutin[®] in 3L R and R Follicular Lymphoma Nordic Nanovector
06-Jul-2022 Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance Boehringer Ingelheim
06-Jul-2022 Eckert & Ziegler Becomes Contract Manufacturer for Clinical Development Candidates Based on Lutetium-177 and Actinium-225 Eckert & Ziegler Strahlen- und Medizintechnik AG
06-Jul-2022 Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance Evotec SE
06-Jul-2022 APONTIS PHARMA rolls out new Single Pill for secondary prophylaxis APONTIS PHARMA AG
06-Jul-2022 Invitation to Cosmo’s Half-Year 2022 Results Webcast on 28 July 2022 Cosmo Pharmaceuticals N.V.